As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired ...
Clinical research organization ICON plc (NASDAQ:ICLR) announced its financial guidance for fiscal year 2025 on Tuesday. What Happened: The Dublin-based company forecasts revenues of $8.05 billion — $8 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback